APO Research

APO RESEARCH · REPORT

AI Drug Safety Prediction Software

Selected research

Industry Growth & Trends

Global AI Drug Safety Prediction Software Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global AI Drug Safety Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI Drug Safety Prediction Software market include Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, Insilico Medicine and MindRank, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI Drug Safety Prediction Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI Drug Safety Prediction Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Safety Prediction Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Safety Prediction Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI Drug Safety Prediction Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI Drug Safety Prediction Software Market by Company

Certara

Lhasa Limited

Instem

ACD/Labs

Chemical Computing Group

Optibrium

MultiCASE

Insilico Medicine

MindRank

Molecular Discovery

Molecular Networks

OASIS LMC

Simulations Plus

Dassault Systèmes

Schrödinger

AI Drug Safety Prediction Software Segment by Type

Integrated ADMET Prediction

Toxicity Endpoint Prediction

Drug-Drug Interaction and PK Safety Prediction

Metabolism and Metabolite Prediction

Off-Target and Safety Pharmacology Prediction

AI Drug Safety Prediction Software Segment by Application

Hit and Lead Screening

Lead Optimization

Candidate Selection

Preclinical Safety Assessment

Regulatory Safety Assessment

Other Drug Safety Research

AI Drug Safety Prediction Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Safety Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Safety Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Safety Prediction Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI Drug Safety Prediction Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Safety Prediction Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI Drug Safety Prediction Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI Drug Safety Prediction Software Market Share by Region (2021-2026) Table 4. Global AI Drug Safety Prediction Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI Drug Safety Prediction Software Market Share by Region (2027-2032) Table 6. Global AI Drug Safety Prediction Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI Drug Safety Prediction Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI Drug Safety Prediction Software Market Size Share by Type (2021-2026) Table 9. Global AI Drug Safety Prediction Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI Drug Safety Prediction Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI Drug Safety Prediction Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI Drug Safety Prediction Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI Drug Safety Prediction Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI Drug Safety Prediction Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI Drug Safety Prediction Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI Drug Safety Prediction Software Market Size Share by Application (2021-2026) Table 24. Global AI Drug Safety Prediction Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI Drug Safety Prediction Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI Drug Safety Prediction Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI Drug Safety Prediction Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI Drug Safety Prediction Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI Drug Safety Prediction Software Industry Trends Table 37. AI Drug Safety Prediction Software Industry Drivers Table 38. AI Drug Safety Prediction Software Industry Opportunities and Challenges Table 39. AI Drug Safety Prediction Software Industry Restraints Table 40. Global AI Drug Safety Prediction Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI Drug Safety Prediction Software Revenue Market Share by Company (2021-2026) Table 42. Global AI Drug Safety Prediction Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI Drug Safety Prediction Software Key Company Headquarters & Area Served Table 44. Global AI Drug Safety Prediction Software Company, Product Type & Application Table 45. Global AI Drug Safety Prediction Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI Drug Safety Prediction Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Certara Company Information Table 49. Certara Business Overview Table 50. Certara AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Certara AI Drug Safety Prediction Software Product Portfolio Table 52. Certara Recent Development Table 53. Lhasa Limited Company Information Table 54. Lhasa Limited Business Overview Table 55. Lhasa Limited AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lhasa Limited AI Drug Safety Prediction Software Product Portfolio Table 57. Lhasa Limited Recent Development Table 58. Instem Company Information Table 59. Instem Business Overview Table 60. Instem AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Instem AI Drug Safety Prediction Software Product Portfolio Table 62. Instem Recent Development Table 63. ACD/Labs Company Information Table 64. ACD/Labs Business Overview Table 65. ACD/Labs AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ACD/Labs AI Drug Safety Prediction Software Product Portfolio Table 67. ACD/Labs Recent Development Table 68. Chemical Computing Group Company Information Table 69. Chemical Computing Group Business Overview Table 70. Chemical Computing Group AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio Table 72. Chemical Computing Group Recent Development Table 73. Optibrium Company Information Table 74. Optibrium Business Overview Table 75. Optibrium AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Optibrium AI Drug Safety Prediction Software Product Portfolio Table 77. Optibrium Recent Development Table 78. MultiCASE Company Information Table 79. MultiCASE Business Overview Table 80. MultiCASE AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. MultiCASE AI Drug Safety Prediction Software Product Portfolio Table 82. MultiCASE Recent Development Table 83. Insilico Medicine Company Information Table 84. Insilico Medicine Business Overview Table 85. Insilico Medicine AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Insilico Medicine AI Drug Safety Prediction Software Product Portfolio Table 87. Insilico Medicine Recent Development Table 88. MindRank Company Information Table 89. MindRank Business Overview Table 90. MindRank AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. MindRank AI Drug Safety Prediction Software Product Portfolio Table 92. MindRank Recent Development Table 93. Molecular Discovery Company Information Table 94. Molecular Discovery Business Overview Table 95. Molecular Discovery AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Molecular Discovery AI Drug Safety Prediction Software Product Portfolio Table 97. Molecular Discovery Recent Development Table 98. Molecular Networks Company Information Table 99. Molecular Networks Business Overview Table 100. Molecular Networks AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Molecular Networks AI Drug Safety Prediction Software Product Portfolio Table 102. Molecular Networks Recent Development Table 103. OASIS LMC Company Information Table 104. OASIS LMC Business Overview Table 105. OASIS LMC AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. OASIS LMC AI Drug Safety Prediction Software Product Portfolio Table 107. OASIS LMC Recent Development Table 108. Simulations Plus Company Information Table 109. Simulations Plus Business Overview Table 110. Simulations Plus AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Simulations Plus AI Drug Safety Prediction Software Product Portfolio Table 112. Simulations Plus Recent Development Table 113. Dassault Systèmes Company Information Table 114. Dassault Systèmes Business Overview Table 115. Dassault Systèmes AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio Table 117. Dassault Systèmes Recent Development Table 118. Schrödinger Company Information Table 119. Schrödinger Business Overview Table 120. Schrödinger AI Drug Safety Prediction Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Schrödinger AI Drug Safety Prediction Software Product Portfolio Table 122. Schrödinger Recent Development Table 123. North America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America AI Drug Safety Prediction Software Market Size by Country (2021-2026) & (US$ Million) Table 125. North America AI Drug Safety Prediction Software Market Share by Country (2021-2026) Table 126. North America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America AI Drug Safety Prediction Software Market Share Forecast by Country (2027-2032) Table 128. Europe AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe AI Drug Safety Prediction Software Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe AI Drug Safety Prediction Software Market Share by Country (2021-2026) Table 131. Europe AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe AI Drug Safety Prediction Software Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific AI Drug Safety Prediction Software Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific AI Drug Safety Prediction Software Market Share by Country (2021-2026) Table 136. Asia-Pacific AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific AI Drug Safety Prediction Software Market Share Forecast by Country (2027-2032) Table 138. Latin America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America AI Drug Safety Prediction Software Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America AI Drug Safety Prediction Software Market Share by Country (2021-2026) Table 141. Latin America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America AI Drug Safety Prediction Software Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa AI Drug Safety Prediction Software Market Share by Country (2021-2026) Table 146. Middle East & Africa AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa AI Drug Safety Prediction Software Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI Drug Safety Prediction Software Product Image Figure 3. Global AI Drug Safety Prediction Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI Drug Safety Prediction Software Market Size (2021-2032) & (US$ Million) Figure 5. Global AI Drug Safety Prediction Software Market Share by Region: 2025 VS 2032 Figure 6. Global AI Drug Safety Prediction Software Market Share by Region (2021-2032) Figure 7. North America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Integrated ADMET Prediction Image Figure 13. Global Integrated ADMET Prediction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Toxicity Endpoint Prediction Image Figure 15. Global Toxicity Endpoint Prediction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Drug-Drug Interaction and PK Safety Prediction Image Figure 17. Global Drug-Drug Interaction and PK Safety Prediction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Metabolism and Metabolite Prediction Image Figure 19. Global Metabolism and Metabolite Prediction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Off-Target and Safety Pharmacology Prediction Image Figure 21. Global Off-Target and Safety Pharmacology Prediction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global AI Drug Safety Prediction Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global AI Drug Safety Prediction Software Market Share by Type 2025 VS 2032 Figure 24. North America AI Drug Safety Prediction Software Market Size Share by Type (2021-2032) Figure 25. Europe AI Drug Safety Prediction Software Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific AI Drug Safety Prediction Software Market Size Share by Type (2021-2032) Figure 27. Latin America AI Drug Safety Prediction Software Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa AI Drug Safety Prediction Software Market Size Share by Type (2021-2032) Figure 29. Hit and Lead Screening Image Figure 30. Global Hit and Lead Screening Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Lead Optimization Image Figure 32. Global Lead Optimization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Candidate Selection Image Figure 34. Global Candidate Selection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Preclinical Safety Assessment Image Figure 36. Global Preclinical Safety Assessment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Regulatory Safety Assessment Image Figure 38. Global Regulatory Safety Assessment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Other Drug Safety Research Image Figure 40. Global Other Drug Safety Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global AI Drug Safety Prediction Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global AI Drug Safety Prediction Software Market Share by Application 2025 VS 2032 Figure 43. North America AI Drug Safety Prediction Software Market Size Share by Application (2021-2032) Figure 44. Europe AI Drug Safety Prediction Software Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific AI Drug Safety Prediction Software Market Size Share by Application (2021-2032) Figure 46. Latin America AI Drug Safety Prediction Software Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa AI Drug Safety Prediction Software Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 AI Drug Safety Prediction Software Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America AI Drug Safety Prediction Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America AI Drug Safety Prediction Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America AI Drug Safety Prediction Software Market Share by Country (2021-2032) Figure 53. Europe AI Drug Safety Prediction Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe AI Drug Safety Prediction Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe AI Drug Safety Prediction Software Market Share by Country (2021-2032) Figure 56. Asia-Pacific AI Drug Safety Prediction Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific AI Drug Safety Prediction Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific AI Drug Safety Prediction Software Market Share by Country (2021-2032) Figure 59. Latin America AI Drug Safety Prediction Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America AI Drug Safety Prediction Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America AI Drug Safety Prediction Software Market Share by Country (2021-2032) Figure 62. Middle East & Africa AI Drug Safety Prediction Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa AI Drug Safety Prediction Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa AI Drug Safety Prediction Software Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Integrated ADMET Prediction
  • Toxicity Endpoint Prediction
  • Drug-Drug Interaction and PK Safety Prediction
  • Metabolism and Metabolite Prediction
  • Off-Target and Safety Pharmacology Prediction
Applications
  • Hit and Lead Screening
  • Lead Optimization
  • Candidate Selection
  • Preclinical Safety Assessment
  • Regulatory Safety Assessment
  • Other Drug Safety Research
Companies covered
  • Certara
  • Lhasa Limited
  • Instem
  • ACD/Labs
  • Chemical Computing Group
  • Optibrium
  • MultiCASE
  • Insilico Medicine
  • MindRank
  • Molecular Discovery
  • Molecular Networks
  • OASIS LMC
  • Simulations Plus
  • Dassault Systèmes
  • Schrödinger

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI Drug Safety Prediction Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI Drug Safety Prediction Software Market Size by Region (2021-2032)
  5. 1.4.1 Global AI Drug Safety Prediction Software Market Size by Region (2021-2026)
  6. 1.4.2 Global AI Drug Safety Prediction Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI Drug Safety Prediction Software Market Size (2021-2032)
  8. 1.5.1 North America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
2 AI Drug Safety Prediction Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Integrated ADMET Prediction
  3. 2.1.2 Toxicity Endpoint Prediction
  4. 2.1.3 Drug-Drug Interaction and PK Safety Prediction
  5. 2.1.4 Metabolism and Metabolite Prediction
  6. 2.1.5 Off-Target and Safety Pharmacology Prediction
  7. 2.2 Global AI Drug Safety Prediction Software Market Size by Type
  8. 2.2.1 Global AI Drug Safety Prediction Software Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global AI Drug Safety Prediction Software Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global AI Drug Safety Prediction Software Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global AI Drug Safety Prediction Software Market Size by Regions
  12. 2.3.1 North America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
3 AI Drug Safety Prediction Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hit and Lead Screening
  3. 3.1.2 Lead Optimization
  4. 3.1.3 Candidate Selection
  5. 3.1.4 Preclinical Safety Assessment
  6. 3.1.5 Regulatory Safety Assessment
  7. 3.1.6 Other Drug Safety Research
  8. 3.2 Global AI Drug Safety Prediction Software Market Size by Application
  9. 3.2.1 Global AI Drug Safety Prediction Software Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global AI Drug Safety Prediction Software Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global AI Drug Safety Prediction Software Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global AI Drug Safety Prediction Software Market Size by Regions
  13. 3.3.1 North America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI Drug Safety Prediction Software Industry Trends
  2. 4.2 AI Drug Safety Prediction Software Industry Drivers
  3. 4.3 AI Drug Safety Prediction Software Industry Opportunities and Challenges
  4. 4.4 AI Drug Safety Prediction Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI Drug Safety Prediction Software Revenue (2021-2026)
  2. 5.2 Global AI Drug Safety Prediction Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI Drug Safety Prediction Software Key Company Headquarters & Area Served
  4. 5.4 Global AI Drug Safety Prediction Software Company, Product Type & Application
  5. 5.5 Global AI Drug Safety Prediction Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI Drug Safety Prediction Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI Drug Safety Prediction Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI Drug Safety Prediction Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Certara
  2. 6.1.1 Certara Company Information
  3. 6.1.2 Certara Business Overview
  4. 6.1.3 Certara AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Certara AI Drug Safety Prediction Software Product Portfolio
  6. 6.1.5 Certara Recent Developments
  7. 6.2 Lhasa Limited
  8. 6.2.1 Lhasa Limited Company Information
  9. 6.2.2 Lhasa Limited Business Overview
  10. 6.2.3 Lhasa Limited AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lhasa Limited AI Drug Safety Prediction Software Product Portfolio
  12. 6.2.5 Lhasa Limited Recent Developments
  13. 6.3 Instem
  14. 6.3.1 Instem Company Information
  15. 6.3.2 Instem Business Overview
  16. 6.3.3 Instem AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Instem AI Drug Safety Prediction Software Product Portfolio
  18. 6.3.5 Instem Recent Developments
  19. 6.4 ACD/Labs
  20. 6.4.1 ACD/Labs Company Information
  21. 6.4.2 ACD/Labs Business Overview
  22. 6.4.3 ACD/Labs AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ACD/Labs AI Drug Safety Prediction Software Product Portfolio
  24. 6.4.5 ACD/Labs Recent Developments
  25. 6.5 Chemical Computing Group
  26. 6.5.1 Chemical Computing Group Company Information
  27. 6.5.2 Chemical Computing Group Business Overview
  28. 6.5.3 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio
  30. 6.5.5 Chemical Computing Group Recent Developments
  31. 6.6 Optibrium
  32. 6.6.1 Optibrium Company Information
  33. 6.6.2 Optibrium Business Overview
  34. 6.6.3 Optibrium AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Optibrium AI Drug Safety Prediction Software Product Portfolio
  36. 6.6.5 Optibrium Recent Developments
  37. 6.7 MultiCASE
  38. 6.7.1 MultiCASE Company Information
  39. 6.7.2 MultiCASE Business Overview
  40. 6.7.3 MultiCASE AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 MultiCASE AI Drug Safety Prediction Software Product Portfolio
  42. 6.7.5 MultiCASE Recent Developments
  43. 6.8 Insilico Medicine
  44. 6.8.1 Insilico Medicine Company Information
  45. 6.8.2 Insilico Medicine Business Overview
  46. 6.8.3 Insilico Medicine AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Insilico Medicine AI Drug Safety Prediction Software Product Portfolio
  48. 6.8.5 Insilico Medicine Recent Developments
  49. 6.9 MindRank
  50. 6.9.1 MindRank Company Information
  51. 6.9.2 MindRank Business Overview
  52. 6.9.3 MindRank AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 MindRank AI Drug Safety Prediction Software Product Portfolio
  54. 6.9.5 MindRank Recent Developments
  55. 6.10 Molecular Discovery
  56. 6.10.1 Molecular Discovery Company Information
  57. 6.10.2 Molecular Discovery Business Overview
  58. 6.10.3 Molecular Discovery AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Molecular Discovery AI Drug Safety Prediction Software Product Portfolio
  60. 6.10.5 Molecular Discovery Recent Developments
  61. 6.11 Molecular Networks
  62. 6.11.1 Molecular Networks Company Information
  63. 6.11.2 Molecular Networks Business Overview
  64. 6.11.3 Molecular Networks AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Molecular Networks AI Drug Safety Prediction Software Product Portfolio
  66. 6.11.5 Molecular Networks Recent Developments
  67. 6.12 OASIS LMC
  68. 6.12.1 OASIS LMC Company Information
  69. 6.12.2 OASIS LMC Business Overview
  70. 6.12.3 OASIS LMC AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 OASIS LMC AI Drug Safety Prediction Software Product Portfolio
  72. 6.12.5 OASIS LMC Recent Developments
  73. 6.13 Simulations Plus
  74. 6.13.1 Simulations Plus Company Information
  75. 6.13.2 Simulations Plus Business Overview
  76. 6.13.3 Simulations Plus AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Simulations Plus AI Drug Safety Prediction Software Product Portfolio
  78. 6.13.5 Simulations Plus Recent Developments
  79. 6.14 Dassault Systèmes
  80. 6.14.1 Dassault Systèmes Company Information
  81. 6.14.2 Dassault Systèmes Business Overview
  82. 6.14.3 Dassault Systèmes AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio
  84. 6.14.5 Dassault Systèmes Recent Developments
  85. 6.15 Schrödinger
  86. 6.15.1 Schrödinger Company Information
  87. 6.15.2 Schrödinger Business Overview
  88. 6.15.3 Schrödinger AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Schrödinger AI Drug Safety Prediction Software Product Portfolio
  90. 6.15.5 Schrödinger Recent Developments
7 North America
  1. 7.1 North America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI Drug Safety Prediction Software Market Size by Country (2021-2026)
  3. 7.3 North America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI Drug Safety Prediction Software Market Size by Country (2021-2026)
  3. 8.3 Europe AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI Drug Safety Prediction Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI Drug Safety Prediction Software Market Size by Country (2021-2026)
  3. 10.3 South America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research